IntraLens Vision Inc., a Lake Forest-based eye device maker, has raised $12 million in venture funds.
The funding was led by a couple of venture investors: Canaan Partners, with offices in Menlo Park and Rowayton, Conn., and InterWest Partners, with offices in Menlo Park and Dallas.
In connection with the funding, the company named Randy Alexander as its chief executive.
Alexander is an eye device veteran who was most recently chief executive of IntraLase Inc., an Irvine-based eye device company, and he also served as an executive of Chiron Vision, which now is part of Bausch & Lomb Inc.
IntraLens plans to use the funding,its third round,for third-phase clinical trials of its lead product, a corneal implant lens to treat presbyopia.
Presbyopia affects people over age 40. It makes reading without glasses difficult.
IntraLens previously was known as Anamed Inc. It was founded in 1996.
It’s not the only Orange County company that’s made news on the presbyopia front of late.
Last month, BioLase Technology Inc., San Clemente, said it was licensing presbyopia-fighting technology from SurgiLight of Orlando, Fla. And Visiogen Inc., an Irvine company, has been developing an implantable lens to fight the condition.
